本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Opko Health

1.53
+0.01000.66%
盤後1.52-0.0100-0.65%19:49 EDT
成交量:182.13萬
成交額:279.28萬
市值:12.14億
市盈率:-5.99
高:1.55
開:1.54
低:1.52
收:1.52
52周最高:2.04
52周最低:1.11
股本:7.94億
流通股本:3.76億
量比:1.31
換手率:0.48%
股息:- -
股息率:- -
每股收益(TTM):-0.2555
每股收益(LYR):-0.0767
淨資產收益率:-13.16%
總資產收益率:-8.46%
市淨率:0.94
市盈率(LYR):-19.95

資料載入中...

2024/09/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/18

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/16

重要事件披露

Form 8-K - Current report
2024/08/30

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/23

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/12

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/07/27

重要事件披露

Form 8-K - Current report
2024/07/26

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/17

重要事件披露

Form 8-K - Current report
2024/07/05

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/06/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/03/29

重要事件披露

Form 8-K - Current report
2024/03/28

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/03/28

重要事件披露

Form 8-K - Current report
2024/03/01

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report